PolarityTE Investor Relations Material
Latest events
Q2 2022
PolarityTE
Q4 2022
27 Mar, 2023
Q3 2022
10 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PolarityTE Inc
Access all reports
PolarityTE, Inc. is a biotechnology company focused on developing regenerative tissue products to treat skin-related conditions. The company’s main product is designed to promote the repair and regeneration of skin tissue in patients with burns, wounds, and other skin injuries. PolarityTE aims to leverage its regenerative medicine technology to improve outcomes in the treatment of complex skin disorders. The company is headquartered in Salt Lake City, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PTE
Country
🇺🇸 United States